Dunhill Financial’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Dunhill Financial's TXG Position: Q3 2026 in Review
Dunhill Financial increased its 10x Genomics (TXG) stake by 8,900% in Q3 2026, buying an estimated $5.21K and bringing the position to 90 shares worth $149. The position accounts for ﹤0.01% of the portfolio, ranked #1366.
Dunhill Financial first reported a position in TXG in Q4 2025 and has held it in 4 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Dunhill Financial held 90 shares of 10x Genomics worth $149 as of Q3 2026.
- Dunhill Financial bought 89 10x Genomics shares in Q3 2026, an estimated $5.21K.
- 10x Genomics made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1366 holding.
- Dunhill Financial first reported a position in 10x Genomics in Q4 2025 and has held it in 4 quarters since.
- 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.